Abstract:The importance of lung microbiome changes in developing chronic lung allograft dysfunction (CLAD) after lung transplantation is poorly understood. The lung microbiome–immune interaction may be critical in developing CLAD. In this context, examining alterations in the microbiome and immune cells of the lungs following CLAD, in comparison to the lung condition immediately after transplantation, can offer valuable insights. Four adult patients who underwent lung retransplantation between January 2019 and June 2020 were included in this study. Lung tissues were collected from the same four individuals at two different time points: at the time of the first transplant and at the time of the explantation of CLAD lungs at retransplantation due to CLAD. We analyzed whole-genome sequencing using the Kraken2 algorithm and quantified the cell fractionation from the bulk tissue gene expression profile for each lung tissue. Finally, we compared the differences in lung microbiome and immune cells between the lung tissues of these two time points. The median age of the recipients was 57 years, and most (75%) had undergone lung transplants for idiopathic pulmonary fibrosis. All patients were administered basiliximab for induction therapy and were maintained on three immunosuppressants. The median CLAD-free survival term was 693.5 days, and the median time to redo the lung transplant was 843.5 days. Bacterial diversity was significantly lower in the CLAD lungs than at transplantation. Bacterial diversity tended to decrease according to the severity of the CLAD. Aerococcus, Caldiericum, Croceibacter, Leptolyngbya, and Pulveribacter genera were uniquely identified in CLAD, whereas no taxa were identified in lungs at transplantation. In particular, six taxa, including Croceibacter atlanticus, Caldiserium exile, Dolichospermum compactum, Stappia sp. ES.058, Kinetoplastibacterium sorsogonicusi, and Pulveribacter suum were uniquely detected in CLAD. Among immune cells, CD8+ T cells were significantly increased, while neutrophils were decreased in the CLAD lung. In conclusion, unique changes in lung microbiome and immune cell composition were confirmed in lung tissue after CLAD compared to at transplantation.

Local intragraft humoral immune responses in chronic lung allograft dysfunction

Lymphocytic Airway Inflammation in Lung Allografts

High-dimensional tissue profiling of immune cell responses in chronic lung allograft dysfunction

Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation.

Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation

Association between Respiratory Virus Infection and Development of De Novo Donor-Specific Antibody in Lung Transplant Recipients

Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation

Unique Changes in the Lung Microbiome following the Development of Chronic Lung Allograft Dysfunction

Impact of Transient and Persistent Donor-Specific Antibodies in Lung Transplantation

Self-reactive Antibodies Associated with Bronchiolitis Obliterans Syndrome Subtype of Chronic Lung Allograft Dysfunction.

Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction

Impact of Alloantibody Strength in Crossmatch Negative DSA Positive Kidney Transplantation

[Lung transplantation : Histomorphological diagnosis and clinical aspects]

Circulating anti-human leukocyte antigen IgM antibodies as a potential early predictor of allograft rejection and a negative clinical outcome after lung transplantation

Macrophage and CD8 T Cell Discordance are Associated with Acute Lung Allograft Dysfunction Progression

Downregulation of Tumor Suppressor Gene LKB1 During Severe Primary Graft Dysfunction After Human Lung Transplantation: Implication for the Development of Chronic Lung Allograft Dysfunction

Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosis

Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study

Late-Onset Exudative Pleural Effusions Without Concomitant Airway Obstruction or Lung Parenchymal Abnormalities: A Novel Presentation of Chronic Lung Allograft Dysfunction

Detailed cellular and spatial characterization of chronic lung allograft dysfunction using imaging mass cytometry

Emergence of a senescent and inflammatory pulmonary CD4 T cell population prior to lung allograft failure